)
Visual
earnings real time
Immunovia (IMMNOV) investor relations material
Immunovia Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary26 Nov, 2025
Executive summary
Transitioned from development to commercial stage with the U.S. launch of PancreaSure, a non-invasive blood test for early pancreatic cancer detection, with initial adoption at 10 leading high-risk surveillance centers and strong advocacy from key opinion leaders.
Launch strategy focused on targeted, low-cost advocacy among key opinion leaders and high-risk centers, with phased commercial investment tied to reimbursement milestones.
Clinical studies, including AFFIRM and CLARITY, demonstrated high sensitivity and specificity, supporting PancreaSure's value in early detection.
Received CAP accreditation for the North Carolina laboratory, confirming high operational standards.
Financial highlights
Q3 2025 net sales were SEK 101,000, primarily from royalty revenue, with PancreaSure test sales expected to impact revenue from Q4 2025.
Operating loss for Q3 2025 was SEK 25.1 million, down from SEK 31.2 million year-over-year.
Cash burn reduced to SEK 5.4 million per month, below previous guidance of SEK 8-10 million.
Ended Q3 with SEK 26.6 million in cash, supported by a 19.0 MSEK bridge loan.
Rights issue post-quarter raised just under SEK 70 million net, with total gross proceeds of up to SEK 100.2 million, extending cash runway into Q3 2026.
Outlook and guidance
Commercial investment will increase as reimbursement milestones are achieved, with significant revenue expected in 2026 and beyond.
Cash position expected to fund operations and clinical studies into Q3 2026.
Expense and cash burn guidance remains at SEK 8-10 million per month, with R&D costs managed within this range.
PancreaSure sales team expansion plans?
Clinical utility evidence strategy details.
How will cash burn change with commercial ramp-up?
Outline the path to Medicare coverage in 2026
What factors influence commercial partner timing?
Describe current PancreaSure physician usage patterns
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Immunovia earnings date
Q4 202524 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Immunovia AB, a Swedish diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company was founded in 2007 and is listed on Nasdaq Stockholm First North Premier under the ticker IMMUV. Immunovia focuses on blood markers with an impact on health risk assessment, prevention and drug development.
The tests have the potential to significantly improve doctors' possibilities to predict and prevent people from getting ill. The most advanced applications for our tests are for important risk groups such as breast cancer patients, heart attack cases, or diabetes type 2 sufferers. Immunovia AB is headquartered in Lund, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage